B
XPH icon

Baird’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Baird’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$7.51M Buy
121,536
+2,228
+2% +$132K 0.08% 254
2014
Q4 		$6.44M Sell
119,308
-400
-0.3% -$21.9K 0.07% 288
2014
Q3 		$6.34M Buy
119,708
+3,402
+3% +$173K 0.09% 210
2014
Q2 		$6.04M Buy
116,306
+1,222
+1% +$58.9K 0.08% 223
2014
Q1 		$5.39M Buy
115,084
+6,494
+6% +$307K 0.08% 254
2013
Q4 		$4.78M Buy
108,590
+1,976
+2% +$82.3K 0.08% 267
2013
Q3 		$4.1M Buy
106,614
+4,622
+5% +$175K 0.08% 293
2013
Q2 		$3.6M Buy
+101,992
New +$3.44M 0.07% 295

Other funds holding XPH

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
HF
Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Baird's XPH Position: Q1 2015 in Review

Baird increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 1.9% in Q1 2015, buying an estimated $132K and bringing the position to 121,536 shares worth $7.51M. The position accounts for 0.08% of the portfolio, ranked #254.

Baird first reported a position in XPH in Q2 2013 and has held it in 8 quarters since. 79 funds tracked by Wall St. Rank hold XPH as of Q1 2015.

  • Baird held 121,536 shares of State Street SPDR S&P Pharmaceuticals ETF worth $7.51M as of Q1 2015.
  • Baird bought 2,228 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2015, an estimated $132K.
  • State Street SPDR S&P Pharmaceuticals ETF made up 0.08% of Baird's portfolio in Q1 2015, its #254 holding.
  • Baird first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and has held it in 8 quarters since.
  • 79 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.